Form 4: Bluebird Bio CEO Sells Shares to Cover Tax Obligations

Bluebird Bio's CEO, Andrew Obenshain, sold 971 shares of common stock at $0.4173 per share to cover tax obligations related to vesting restricted stock units.

Summary

• Andrew Obenshain, the President and CEO of Bluebird Bio, sold 971 shares of the company's common stock on December 10, 2024.
• The shares were sold at a price of $0.4173 per share.
• This transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Mr. Obenshain directly owns 374,247 shares of Bluebird Bio stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, not indicative of positive or negative sentiment towards the company's prospects.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax liabilities when restricted stock units vest.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a common practice across publicly traded companies.
• The sale of 971 shares is relatively small compared to the total holdings of 374,247 shares, suggesting this is a routine transaction rather than a significant divestment.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a small sale by the CEO to cover tax obligations.

Key Dates

Keywords

insider trading, stock sale, executive compensation, restricted stock units, tax obligations, bluebird bio, obenshain